The invention relates to the use of 8-hydroxyquinoline 7-carboxylic acid derivatives in order to produce integrase-inhibiting medicaments, capable of blocking viral replication in the stages preceding integration, and if appropriate at the level of this integration stage, these medicaments being usable for the treatment of retroviral pathologies, in particular for the treatment of AIDS.

 
Web www.patentalert.com

< 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators

> 1H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB.sub.1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activity
~ 00492